References
- Petranyi G, Ryder N S, Stütz A. Allylamine derivatives: New class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 1984; 224: 1239–41
- Georgopoulos A G, Petranyi G, Mieth H, et al. In vitro activity of naftifine, a new antifungal agent. Antimicrob Agents Chemother 1981; 19: 386–9
- Stütz A. Synthesis and structure-activity correlations within allylamine antimycotics. Ann N YAcad Sci 1988; 544: 46–62
- Petranyi G, Meingassner J G, Mieth H. Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother 1987; 31: 1365–8
- Ryder N S, Mieth H. Allylamine antifungal drugs. Current topics in medical mycology, M Borgers, R J Hay, M G Rinaldi. Springer-Verlag, New York 1982; vol. 4: 158–88
- Paltauf F, Daum G, Zuder G, et al. Squalene and ergosterol biosynthesis in fungi treated with naftifine, a new antimycotic agent. Biochim Biophys Acta 1982; 712: 268–73
- Ryder N S, Seidl G, Troke P F. Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albi-cans. Antimicrob A gents Chemother 1984; 25: 483–7
- Ryder N S. Specific inhibition of fungal sterol biosynthesis by SF 86–327, a new allylamine antimycotic agent. Antimicrob Agents Chemother 1985; 27: 252–6
- Ryder N S. Effect of allylamine antimycotic agents on fungal sterol biosynthesis measured by sterol side-chain methylation. J Gen Microbiol 1985; 131: 1595–602
- Ryder N S. Mode of action of allylamines. Sterol biosynthesis inhibitors. Pharmaceutical and agrochemical aspects, D Berg, M Plempel. Ellis Horwood Ltd, Chichester 1988; 151–67
- Ryder N S, Seidl G, Petranyi G, . Mechanism of the fungicidal action of SF 86–327, a new allylamine antimycotic agent. Recent advances in chemotherapy, J Ishigami, et al. University of Tokyo Press, Tokyo 1985; 2258–9
- Gnamusch E, Ryder N S, Paltauf F. Effect of squalene on the structure and function of fungal membranes. J Dermatol Treat 1992, this issue
- Ryder N S. Squalene epoxidase: Enzymology and inhibition. Biochemistry of cell walls and membranes in fungi, P J Kuhn, A PJ Trinci, M J Jung, et al. Springer-Verlag, Berlin 1990; 189–203
- Ryder N S, Stlltz A, Nussbaumer P. Squalene epoxidase inhibitors: Structural determinants for activity and selectivity of allylamines and related compounds. Regulation of isopentenoid metabolism, W D Nes, E J Parish. American Chemical Society, Washington, DC 1992; 192–204
- Ryder N S, Dupont M-C. Inhibition of squalene epoxidase by allylamine antimycotic compounds: A comparative study of the fungal and mammalian enzymes. Biochem J 1985; 230: 765–70
- Ryder N S. Squalene epoxidase as the target of antifungal allylamines. Pestic Sci 1987; 21: 281–8
- Ryder N S. Inhibition of squalene epoxidase and sterol side-chain methylation by allylamines. Biochem Soc Trans 1990; 18: 45–6
- Ryder N S. Mechanism of action and biochemical selectivity of allylamine antimycotic agents. Ann N Y Acad Sci 1988; 544: 208–20
- Schuster I. The interaction of representative members from two classes of antimycotics — the azoles and the allylamines —with cytochromes P-450 in steroidogenic tissues and liver. Xenobiotica 1985; 15: 529–46
- Schuster I. Potential of allylamines to inhibit cytochrome P-450. Recent trends in the discovery, development and evaluation of antifungal agents, R A Fromtling. J R Prous Science Publishers, Barcelona 1987; 471–8
- Jensen J C, Back D J. Interaction of terbinafine with cytochrome P-450 in vitro and in vivo in man. Br J Clin Pharnacol 1988; 26: 236P
- Back D J, Tjia J F, Abel S M. Azoles, allylamines and drug metabolism. Br J Dermatol 1992; 126(suppl 39)14–8
- Ryder N S. Terbinafine: Mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol 1992; 126(suppl 39)2–7